Skip to content

Orange Book Blog

At the intersection of Patent and FDA Law

    • About
    • Authors
    • Disclaimer

Recent Posts

  • Hikma v. Vanda: Oral Argument Recap
  • Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
  • Should ANDA filers be using the PTAB to mount early challenges to OB patents?
  • Switching to WordPress
  • Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases

  • Twitter
  • Facebook
  • Instagram

Switching to WordPress

September 30, 2025

TypePad has shut down on us, so we’re moving the blog to WordPress. Thank you for your patience as we learn how to navigate this new blog!

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
Like Loading…
Posted in Uncategorized

Leave a comment Cancel reply

←Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases
Should ANDA filers be using the PTAB to mount early challenges to OB patents?→

Blog at WordPress.com.

  • Comment
  • Reblog
  • Subscribe Subscribed
    • Orange Book Blog
    • Already have a WordPress.com account? Log in now.
    • Orange Book Blog
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
%d